Page last updated: 2024-10-23

astemizole and Cancer of Lung

astemizole has been researched along with Cancer of Lung in 2 studies

Astemizole: Antihistamine drug now withdrawn from the market in many countries because of rare but potentially fatal side effects.
astemizole : A piperidine compound having a 2-(4-methoxyphenyl)ethyl group at the 1-position and an N-[(4-fluorobenzyl)benzimidazol-2-yl]amino group at the 4-position.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chatziantoniou, A1
Zaravinos, A1
Ellegaard, AM1
Dehlendorff, C1
Vind, AC1
Anand, A1
Cederkvist, L1
Petersen, NHT1
Nylandsted, J1
Stenvang, J1
Mellemgaard, A1
Østerlind, K1
Friis, S1
Jäättelä, M1

Other Studies

2 other studies available for astemizole and Cancer of Lung

ArticleYear
Signatures of Co-Deregulated Genes and Their Transcriptional Regulators in Lung Cancer.
    International journal of molecular sciences, 2022, Sep-18, Volume: 23, Issue:18

    Topics: Adenocarcinoma of Lung; Astemizole; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms;

2022
Repurposing Cationic Amphiphilic Antihistamines for Cancer Treatment.
    EBioMedicine, 2016, Volume: 9

    Topics: A549 Cells; Adult; Apoptosis; Astemizole; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cations

2016